{
  "id": 20618179,
  "title": "Lonza at Jefferies Global Healthcare Conference: focus on cdmo growth",
  "url": "https://urgent.news/2026/11/18/lonza-at-jefferies-global-healthcare-conference-focus-on-cdmo-growth",
  "topic": "business",
  "section": "Business",
  "published": "2026-11-18T16:10:18.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/lonza-at-jefferies-global-healthcare-conference-focus-on-cdmo-growth-93CH-5036630"
  },
  "original_language": "en",
  "account": "On Wednesday, November 18th, 2026, Lonza, the Swiss contract development and manufacturing organization (CDMO), addressed investors at the Jefferies Global Healthcare Conference. CEO Wolfgang Wienand outlined a new strategy centered around growth, capacity, and a more focused business model.\n\nThe presentation indicated that Lonza is transitioning towards a pure-play CDMO model, even as some restructuring efforts temporarily impact margins. Shareholders can expect stronger sales growth, higher profitability, and an expanding customer base, despite the costs associated with restructuring and the sale of non-core assets.\n\nLonza aims for organic sales growth averaging in the low teens over time, with EBITDA margins expected to rise by 4 percentage points since 2024. The company has invested in a CHF 8 billion CapEx pipeline, consisting of 25 projects with expected returns of 30% to 40%.\n\nIn addition to this growth strategy, Lonza has acquired Merck KGaA’s U.S. CDMO network, adding capacity in bioconjugation, viral vectors, and lipid nanoparticle formulation. The company is investing in its existing assets, such as the Vacaville facility, even if some are temporarily dilutive.\n\nWienand emphasized that the company is organized around six strategic imperatives, with the primary goal of becoming a focused CDMO business. The restructuring has already led to the sale of the CHI business for CHF 1.6 billion to 1.7 billion, and the transition to the new operating model took place on April 1, 2025.\n\nThe company's strategy is based on its \"Lonza engine,\" which combines high-performance teams, scientific and technological strength, customer partnerships, execution discipline, and the ability to quickly invest and integrate. Lonza differentiates itself by solving manufacturability issues rather than merely providing procurement services.\n\nOverall, Lonza's organic sales growth is projected to average in the low teens, with EBITDA margins expanding by 4 percentage points since 2024. The company's market capitalization stands at $55.3 billion, and it reported revenue growth of 26% over the last twelve months, significantly surpassing its long-term targets.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}